featured
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Versus Cytoreductive Surgery Alone for Colorectal Peritoneal Metastases (PRODIGE 7): A Multicentre, Randomised, Open-Label, Phase 3 Trial
Lancet Oncol 2021 Jan 18;[EPub Ahead of Print], F Quénet, D Elias, L Roca, D Goéré, L Ghouti, M Pocard, O Facy, C Arvieux, G Lorimier, D Pezet, F Marchal, V Loi, P Meeus, B Juzyna, H de Forges, J Paineau, O GlehenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.